Neuroimaging plays a pivotal role in the diagnosis, management, and prognostication of brain tumors. Recently, the World Health Organization published the fifth edition of the WHO Classification of Tumors of the Central Nervous System (CNS5), which places greater emphasis on tumor genetics and molecular markers to complement the existing histological and immunohistochemical approaches. Recent advances in computational power allowed modern neuro-oncological imaging to move from a strictly morphology-based discipline to advanced neuroimaging techniques with quantifiable tissue characteristics such as tumor cellularity, microstructural organization, hemodynamic, functional, and metabolic features, providing more precise tumor diagnosis and management. The aim of this review is to highlight the key imaging features of the recently published CNS5, outlining the current imaging standards and summarizing the latest advances in neuro-oncological imaging techniques and their role in complementing traditional brain tumor imaging and management.
Keywords: Artificial intelligence; Brain tumor; CEST; CT Perfusion; Central Nervous System; Diffusion-weighted imaging; FDG PET; Imaging; MR perfusion; Machine learning; Neuroimaging; Neurooncological; WHO CNS5; WHO Classification; diffusion-tensor imaging (DTI); fMRI.
Copyright © 2023. Published by Elsevier Inc.